Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function
Authors:
- E SchültkeESE Schültke
- H KamencicHKH Kamencic
- V M SkiharVSV M Skihar
- R GriebelRGR Griebel
- B JuurlinkBJB Juurlink
- 8 September 2009
- journal article
- Published by Springer Nature in Spinal Cord
- Vol. 48 (2) , 112-117
Abstract
We have shown previously that administration of quercetin after spinal cord injury in a rat model induced significant recovery of motor function. In the same model for spinal cord compression injury, we now have correlated the treatment duration with the extent to which motor function is recovered. Seventy-four male Wistar rats were assigned to eight experimental groups. Mid-thoracic spinal cord injury was produced in the animals of seven groups. Quercetin was administered intraperitoneally in individual doses of 25 micromol kg(-1). Treatment onset was 1 h after the injury. The length of treatment ranged from one single injection to 10 days, with injection frequencies of two or three times daily. BBB (Basso, Beattie and Bresnahan) scores were obtained and tissue preservation at the site of injury was analyzed. None of the untreated control animals recovered motor function sufficient to walk. When quercetin was administered twice daily over a period of either 3 or 10 days, about 50% of the animals recovered sufficient motor function to walk. Stepping/walking (BBB > or =10) were seen in two of six animals receiving only a single injection and in one of the six animal receiving three injections. Surprisingly, none of the animals that received quercetin injections three times daily recovered the ability to walk (all BBB < or = 9). Quercetin administration results in preservation of tissue bridges at the site of injury. Treatment success depends on frequency of administration and overall dose.Keywords
This publication has 16 references indexed in Scilit:
- Neuroprotection following Fluid Percussion Brain Trauma: A Pilot Study Using QuercetinJournal of Neurotrauma, 2005
- Quercetin Promotes Functional Recovery Following Acute Spinal Cord InjuryJournal of Neurotrauma, 2003
- Disposition of the Flavonoid Quercetin in Rats After Single Intravenous and Oral DosesDrug Development and Industrial Pharmacy, 2003
- Acute Inflammatory Response in Spinal Cord Following Impact InjuryExperimental Neurology, 1998
- Vascular mechanisms in the pathophysiology of human spinal cord injuryJournal of Neurosurgery, 1997
- MASCIS Evaluation of Open Field Locomotor Scores: Effects of Experience and Teamwork on ReliabilityJournal of Neurotrauma, 1996
- Update on the Pathophysiology and Pathology of Acute Spinal Cord InjuryBrain Pathology, 1995
- A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in RatsJournal of Neurotrauma, 1995
- Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanismsJournal of Neurosurgery, 1991
- Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compoundsCellular and Molecular Life Sciences, 1988